During the past decade, Mercy Research conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Mercy Research" #1 collaborator was "Janssen, LP" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Mercy Research" are "Chronic Lymphocytic Leukemia (CLL)" (1 trials) and "Multiple Myeloma" (1 trials). Many other conditions were trialed in "Mercy Research" in a lesser frequency.

The vast majority of trials in "Mercy Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mercy Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Mercy Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Mercy Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".